Acceleron Pharma Inc (NASDAQ:XLRN)

106.17
Delayed Data
As of 4:00pm ET
 -2.28 / -2.10%
Today’s Change
40.15
Today|||52-Week Range
124.01
+100.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues18.1M27.8M13.5M14.0M
 
 
 
 
 
Depreciation And Amortization1.2M1.7M2.8M3.7M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses77.8M92.2M120.6M134.7M
 
 
 
 
 
Research And Development58.4M68.6M89.7M103.9M
 
 
 
 
 
Total Operating Expenses79.0M93.9M123.5M138.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-60.9M-66.1M-110.0M-124.4M
 
 
 
 
 
Extraordinary Credit0.007.3M0.000.00
 
 
Extraordinary Charge-3.5M0.00-992.0K-52.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-63.9M-57.0M-108.4M-118.9M
 
 
 
 
 
Income Taxes0.00-24.0K-32.0K-27.0K
 
 
 
 
Net Income-63.9M-57.0M-108.5M-118.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS33.3M37.4M40.4M45.9M
 
 
 
 
 
Shares To Calculate EPS Diluted33.3M37.4M40.4M45.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.92-$1.52-$2.68-$2.59
 
 
 
 
 
EPS Diluted-$1.92-$1.52-$2.68-$2.59